A Study to Evaluate the Long-term Safety, Tolerability, and Efficacy of Subcutaneous Sonelokimab in Participants With Moderate to Severe Hidradenitis Suppurativa
Clinical trial NCT07007637 · ENROLLING_BY_INVITATION
Trial details
- NCT number
- NCT07007637
- Sponsor
- MoonLake Immunotherapeutics AG
- Status
- ENROLLING_BY_INVITATION
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2025-06-27
- Primary completion
- 2028-06-13
- Enrollment
- 835
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.